Autoimmune lymphoproliferative syndrome primary prevention
|
Autoimmune lymphoproliferative syndrome Microchapters |
|
Differentiating Autoimmune lymphoproliferative syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Autoimmune lymphoproliferative syndrome primary prevention On the Web |
|
American Roentgen Ray Society Images of Autoimmune lymphoproliferative syndrome primary prevention |
|
FDA on Autoimmune lymphoproliferative syndrome primary prevention |
|
CDC on Autoimmune lymphoproliferative syndrome primary prevention |
|
Autoimmune lymphoproliferative syndrome primary prevention in the news |
|
Blogs on Autoimmune lymphoproliferative syndrome primary prevention |
|
Directions to Hospitals Treating Autoimmune lymphoproliferative syndrome |
|
Risk calculators and risk factors for Autoimmune lymphoproliferative syndrome primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
An autoimmune lymphoproliferative syndrome(ALPS) is a genetic disorder that is inherited in most cases. So, there are no primary prevention guidelines so far.
Primary Prevention
For the individuals with severe clinical phenotypes as ALPS-FAS which is caused by biallelic pathogenic variants, having severe refractory cytopenias developed lymphoma, or having complications from immunosuppressive therapy require bone marrow transplant which might be the only curative treatment.[1]